Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) Files An 8-K Other Events
Item 8.01.
Other Events.
On February 21, 2019, Ohr Pharmaceutical, Inc. (the “Company”) issued a press release announcing that it received notice from The Nasdaq Stock Market LLC indicating that the Company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). This press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
| Item 9.01 | Financial Statements and Exhibits. |
(d)
Exhibits:
| 99.1 | Press release, dated February 21, 2019 |
Ohr Pharmaceutical Inc Exhibit
EX-99.1 2 ex99-1.htm PRESS RELEASE Ohr Pharmaceutical,…
To view the full exhibit click here
